SciLifeLab

IP Strategies for Academic Startups, Pharma and Biotech Companies in the Life Sciences
2024-12-18 11:00 - 12:00 (Europe/Stockholm) | Online event via Zoom
Welcome to this Drug Discovery Webinar, organized by OligoNova and SciLifeLab Drug Discovery and Development.

This seminar will build on the previous sessions on regulatory protection and trade secrets, aiming to provide real world examples of how these approaches can be used to drive the growth of start-ups. Come with your questions and experiences to share!

registration

Agenda

Introduction – Fredrik Wångsell, OligoNova

IP Strategies in the Life Sciences – Fiona Hey, Tony Proctor and Michel Pears Potter Clarkson

Bio-tech start-up/company that used trade secrets successfully (to be announced)

Input from your own experiences

Discussion

Q&A

Welcome

SciLifeLab DDD and OligoNova

Other Seminars

OligaNova organizes three seminars during the fall 2024

Trade secrets in the Life Sciences, October 15

Maximizing exclusivity in the Life Sciences, November 6

IP Strategies in the Life Sciences, December 18

Maximising exclusivity for Academic Startups, Pharma and Biotech Companies in the Life Sciences
2024-11-06 11:00 - 12:00 | Online event via Zoom
Welcome to this Drug Discovery Webinar, organized by OligoNova and SciLifeLab Drug Discovery and Development, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients.

Join us for an insightful seminar focusing on strategies to maximize the exclusivity of medicinal products in the marketplace. This session will delve into the intricacies of regulatory intellectual property (IP), including patenting strategies, patent term extensions such as Supplementary Protection Certificates (SPCs), and regulatory exclusivities like data and market exclusivity. Additionally, we will explore further exclusivities available for orphan and paediatric medicines.

The seminar will emphasise the critical role of exclusivity in attracting and securing investor interest. Gain valuable knowledge on how to navigate and leverage these mechanisms to extend the market life of your medicinal products effectively, thereby enhancing their appeal to potential investors.

registration

Agenda

Introduction – Fredrik Wångsell, OligoNova

Maximizing exclusivity in the Life Sciences – Fiona Hey, Tony Proctor and Michel Pears, Potter Clarkson

Q&A and discussion

One follow-up webinar will take place later this year <ADD LINK>

Welcome

SciLifeLab DDD and OligoNova

Other Seminars

OligaNova organizes three seminars during the fall 2024

Trade secrets in the Life Sciences, October 15

Maximizing exclusivity in the Life Sciences, November 6

IP Strategies in the Life Sciences, December 18

Trade secrets for Academic Startups, Pharma and Biotech Companies in the Life Sciences
2024-10-15 11:00 - 12:00 | Online event via Zoom
Welcome to this Drug Discovery Webinar, organized by OligoNova and SciLifeLab Drug Discovery and Development, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients.

This webinar is an introduction to trade secrets as a form of intellectual property, with a focus on its potential importance to a life sciences start up.

Trade secrets are often an overlooked form of intellectual property, thought by many to be of little relevance in the life sciences. However, as part of a well-developed IP strategy, trade secrets have an increasingly important role to play, with the potential to not only supplement a patent-based strategy but, in some cases, to provide a more suitable alternative.

In this seminar, we will discuss how trade secrets can be identified, protected, and used to increase value and support investment.

registration

Agenda

Introduction – Fredrik Wångsell, OligoNova

Trade secrets in the Life Sciences – Fiona Hey, Tony Proctor and Michel, Pears Potter Clarkson

Q&A and discussion

Welcome

SciLifeLab DDD and OligoNova

Other Seminars

OligaNova organizes three seminars during the fall 2024

Trade secrets in the Life Sciences, October 15

Maximizing exclusivity in the Life Sciences, November 6

IP Strategies in the Life Sciences, December 18

Patentability and Strategies for Novel Therapeutic Oligonucleotides
2024-04-09 13:00 - 15:00 | GoCo House, Allvar Gullstrand, Entreprenörsstråket 10, Mölndal, 431 53, Sweden
Welcome to this seminar to learn more about intellectual properties regarding therapeutic oligonucleotides and strategies how to protect your invention. The seminar is organized by OligoNova Hub and SciLifeLab Drug Discovery and Development and is a hybrid event (Zoom or in-person at GoCo House).

Agenda

Introduction

OligoNova Hub/ScilifeLab DDD: Pär Matsson, 5 min

AstraZeneca: Peter Storm 20 min

Ribocure: (TBC) 20 min

Patentability and Strategies for Therapeutic Oligonucleotides

Potter Clarkson: Fiona Hey, Kevin Rich and Louise Tottie

Panel discussion questions

Moderator: OligoNova Hub/DDD

Moderator: OligoNova Hub/DDD

Protecting your innovation and future proofing your enterprise may well mean the difference between commercial success and disappointment. However, it is not always obvious what IP you have, what you might be able to protect and what is worthwhile protecting. With a focus on oligonucleotide inventions, we will guide you through the requirements for patentability, highlighting the challenges associated with oligonucleotides and outlining an IP strategy that you can apply to help you to achieve your commercial goals.

For those that attend the seminar in person, there will be time to continue the discussion after the program with IP attorneys and academic and industrial scientist working with therapeutic oligonucleotides. Coffee and cake will be served.

Prior this hybrid event there will be a more general webinar (March 25, at 1 pm) “Patent Fundamentals for Academia and Biotech Inventions”.

OligoNova Hub offers industry-standard research and development capabilities to Swedish academic researchers, helping to transform their ideas into new oligonucleotide therapies. OligoNova Hub is part of the national SciLifeLab Drug Discovery and Development infrastructure, supporting academic researchers in drug discovery and development towards innovative commercial assets that will benefit patients.

Registration

registration

Organizer

Fredrik Wångsell, Research Advisor at OligoNova Hub/SciLifeLab Oligonucleotide Therapeutics Unit

Patent Fundamentals for Biotech Inventions
2024-03-25 13:00 - 14:00 | Online event via Zoom
Welcome to this webinar, organized by OligoNova and SciLifeLab Drug Discovery and Development, to learn more about how academic and biotech interventions can be protected with the goal to benefit patients. Understanding what can be claimed in a patent application, what data is needed, the patenting process, who owns an invention, and whether one has freedom to operate can be challenging. A strong intervention of early projects is one part needed to be as attractive as possible for the way forward in drug development. In this webinar, Fiona Hey, Kevin Rich and Louise Tottie from Potter Clarkson will guide you through these fundamental topics in preparation for our second seminar, focused on therapeutic oligonucleotide inventions, April 9, Patentability and Strategies for Therapeutic Oligonucleotides

Agenda

Introduction

OligoNova, 5 min

Patent Fundamentals for Academic and Biotech Inventions

Potter Clarkson: Fiona Hey, Kevin Rich and Louise Tottie, 60 min

Q&A: 25 min moderated by OligoNova

Speakers

Fredrik Wångsell, OligoNova Hub/SciLifeLab

Fiona Hey, Potter Clarkson

Kevin Rich, Potter Clarkson

Louise Tottie, Potter Clarkson

Registration

Information meeting – Call for Therapeutic Oligonucleotide Projects at OligoNova Hub / SciLifeLab DDD
2022-04-04 14:00 - 15:00 | Online event via Zoom
The mission of the Drug Discovery and Development Platform at SciLifeLab is to support researchers in developing new drugs, transforming academic ideas into new treatments. Therapeutic oligonucleotides is a recent addition to the Drug Discovery and Development platform’s capacity, available through the OligoNova Hub in Gothenburg.

Now, the first call for therapeutic oligonucleotide projects is opening (March 28 – May 13, 2022).

At this online information meeting, there will be a presentation of the call and you as an applicant will have the opportunity to ask questions about the call and the application process.

The call text will be published via the SciLifeLab and OligoNova websites on March 28.

Register here

OligoNova Hub is a national facility providing academic researchers in Sweden with support and capabilities to convert ideas and discoveries into potential new oligonucleotide therapies. OligoNova Hub is part of the SciLifeLab Drug Discovery and Development platform, and is located at the AZ BioVentureHub campus in Gothenburg. The OligoNova Hub offers full capacity for the design, synthesis, evaluation and optimization of therapeutic oligonucleotides to academic researchers. The hub has been made possible through support from the Knut and Alice Wallenberg foundation, SciLifeLab, University of Gothenburg, Region Västra Götaland, and a donation from Carl Bennet.
